Breast Cancer Index Predicts Extended Endocrine Benefit to Individualize Selection of Patients with HR+ Early-stage Breast Cancer for 10 Years of Endocrine Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Breast Cancer Index Predicts Extended Endocrine Benefit to Individualize Selection of Patients with HR+ Early-stage Breast Cancer for 10 Years of Endocrine Therapy

Published:2020-10-27 Issue:1 Volume:27 Page:311-319
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Noordhoek Iris^ORCID,Treuner Kai,Putter Hein,Zhang Yi,Wong Jenna,Meershoek-Klein Kranenbarg Elma^ORCID,Duijm-de Carpentier Marjolijn^ORCID,van de Velde Cornelis J.H.,Schnabel Catherine A.,Liefers Gerrit-Jan

Funder

Leiden University Medical Center Institutional Grant

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor–Positive Breast Cancer;JAMA Oncology;2024-08-15

2. ERBB2/HOXB13co-amplification with interstitial deletion ofBRCA1defines a unique subset of breast cancers;2024-08-07

3. Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial;Journal of Clinical Oncology;2024-07-24

4. TAILORing Estimates of Late Breast Cancer Recurrence with the RSClin Tool;NEJM Evidence;2024-07-23

5. Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP